Retina Treatment

According to All India Institute of Medical Sciences, New Delhi, anti-Vascular Endothelial Growth Factor (anti-VEGF) injection often remain the mainstay of treatment for blinding retinal disorders like Diabetic Macular Edema (EME), wet age related Macular Degeneration (AMD) and Retinal Vein Occlusion etc. The vision of the patients suffering with these diseases and related disorders, improves by giving anti VEGF injection, namely injection Lucentis, injection Avastin or injection Macugen, which may need to be repeated for optimal treatment. Use of the anti VEGF injection for treatment of retinal diseases has been approved by the Drugs Controller General of India (DCGI), which is the regulatory body for introduction of new drugs.



All India Institute of Medical Sciences, New Delhi informed that it is not true that repeated injection causes visual loss. However, it may actually improve the vision of the patient. Rarely, in less than 0.1-0.2% eyes, infection within the eye could occur, which is then effectively managed by the Ophthalmologist concerned. These injections are expensive, but with CGHS,ECHS (Armed Forces) and other Government and semi-autonomous bodies, complete reimbursement is provided to the suffering patients. Also patients with health insurance get it reimbursed from the Insurance Company.



This information was given by the Union Minister of Health & Family Welfare ShriGhulamNabi Azadin written reply to a question in the LokSabha yesterday.



Source:pib